Cargando…
Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway
Bladder cancer (BC) is the second most common urologic malignancy and the ninth most common malignancy worldwide. Surgical resection is the mainstay of treatment for patients with early-stage disease, whereas therapeutic options are limited for patients with advanced-stage or residual BC. Programmed...
Autores principales: | Tsai, Te-Fu, Lin, Ji-Fan, Lin, Yi-Chia, Chou, Kuang-Yu, Chen, Hung-En, Ho, Chao-Yen, Chen, Po-Chun, Hwang, Thomas I-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783655/ https://www.ncbi.nlm.nih.gov/pubmed/31341011 http://dx.doi.org/10.1042/BSR20190362 |
Ejemplares similares
-
Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells
por: Lin, Ji-Fan, et al.
Publicado: (2017) -
Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway
Publicado: (2020) -
Miconazole Contributes to NRF2 Activation by Noncanonical P62-KEAP1 Pathway in Bladder Cancer Cells
por: Tsai, Te-Fu, et al.
Publicado: (2020) -
MicroRNA-34a-5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase-2 silencing
por: Chou, Kuang-Yu, et al.
Publicado: (2021) -
Thrombospondin‐4 promotes bladder cancer cell migration and invasion via MMP2 production
por: Chou, Kuang‐Yu, et al.
Publicado: (2021)